SENS.A
Latest Trade
1.06USDChange
-0.01(-0.93%)Volume
45,650Today's Range
-
1.0952 Week Range
-
4.88As of on the NYSE MKT LLC ∙ Minimum 15 minute delay
Previous Close | 1.07 |
|---|---|
Open | 1.07 |
Volume | 45,650 |
3M AVG Volume | 42.43 |
Today's High | 1.09 |
Today's Low | 1.06 |
52 Week High | 4.88 |
52 Week Low | 0.93 |
Shares Out (MIL) | 203.17 |
Market Cap (MIL) | 223.49 |
Forward P/E | -1.70 |
Dividend (Yield %) | -- |
Senseonics Holdings Inc Files For Offering Of Convertible Senior Notes Of Up To $82.0 Million
Senseonics Holdings Q2 Loss Per Share $0.17
Senseonics Announces Pricing Of Public Offering Of Common Stock
Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.
Industry
Medical Equipment & Supplies
Executive Leadership
Stephen P. DeFalco
Independent Chairman of the Board
Timothy T. Goodnow
President, Chief Executive Officer, Director
Jon D. Isaacson
Chief Financial Officer, Treasurer, Secretary
Mukul Jain
Chief Operating Officer
Michael J. Gill
Vice President and General Manager - U.S. Region
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | 10.97 |
Price To Book (MRQ) | 12.83 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 314.48 |
LT Debt To Equity (MRQ) | 249.23 |
Return on Investment (TTM) | -80.22 |
Return on Equity (TTM) | -64.90 |
* SENSEONICS ANNOUNCES EXTENSION OF DISTRIBUTION AGREEMENT WITH ROCHE DIABETES CARE
* SENSEONICS - ON DEC. 20, UNIT ENTERED INTO AMENDMENT WITH ROCHE TO THEIR MAY 23, 2016 DISTRIBUTION AGREEMENT TO EXTEND AGREEMENT TERM UNTIL JAN. 31, 2019
* SENSEONICS HOLDINGS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
* SENSEONICS HOLDINGS INC FILES FOR MIXED SHELF OF UP TO $200 MILLION - SEC FILING Source text: [https://bit.ly/2qJDrDR] Further company coverage:
* SENSEONICS HOLDINGS INC FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING Source text: [https://bit.ly/2GDV1lV] Further company coverage:
* SENSEONICS ANNOUNCES FAVORABLE OUTCOME OF FDA ADVISORY COMMITTEE ON THE EVERSENSE SYSTEM
* SENSEONICS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
* SENSEONICS ANNOUNCES PROPOSED CONVERTIBLE SENIOR SUBORDINATED NOTES OFFERING
* Senseonics Holdings Inc reports third quarter 2017 financial results
* Senseonics announces CE mark approval for Eversense® XL CGM System
* Senseonics Holdings Inc announces pricing of public offering of common stock
* Senseonics Holdings Inc announces proposed public offering of common stock
* Roche Holding Ltd reports a 23.62 percent stake in Senseonics Holdings Inc as of June 1, 2017 - SEC filing Source text for Eikon: (http://bit.ly/2sKcWOf) Further company coverage:
* Senseonics announces pricing of $41 million underwritten offering of common stock
* Temasek Holdings (Private) Ltd takes share stake of 300,000 shares in Snap Inc - sec filing
* Senseonics Holdings Inc eeports first quarter 2017 financial results
* Senseonics Holdings Inc files for mixed shelf of up to $150 million - SEC filing Source text : [http://bit.ly/2ov35fC] Further company coverage:
* Senseonics Holdings Inc says third tranche of $5 million was triggered by first sale of Senseonics' second generation transmitter in Europe Source text for Eikon: Further company coverage:
* Senseonics Holdings Inc reports fourth quarter 2016 financial results
* Roche Holding Ltd reports 8.5% passive stake in Senseonics Holdings Inc as of December 31, 2016 - SEC Filing Source text: [http://bit.ly/2lhzCEQ] Further company coverage:
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.